Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

This study has been terminated.
(administrative reasons)
Sponsor:
Information provided by:
InterMune
ClinicalTrials.gov Identifier:
NCT00057447
First received: April 1, 2003
Last updated: October 30, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2004
  Estimated Primary Completion Date: No date given